Page last updated: 2024-09-03
zd 7114 and bucindolol
zd 7114 has been researched along with bucindolol in 1 studies
Compound Research Comparison
Studies (zd 7114) | Trials (zd 7114) | Recent Studies (post-2010) (zd 7114) | Studies (bucindolol) | Trials (bucindolol) | Recent Studies (post-2010) (bucindolol) |
---|---|---|---|---|---|
35 | 2 | 3 | 141 | 38 | 39 |
Protein Interaction Comparison
Protein | Taxonomy | zd 7114 (IC50) | bucindolol (IC50) |
---|---|---|---|
Cytochrome P450 2D6 | Homo sapiens (human) | 0.05 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Baker, JG; Fretwell, L; Gardiner, SM; Hill, SJ; Kemp, P; March, J | 1 |
Other Studies
1 other study(ies) available for zd 7114 and bucindolol
Article | Year |
---|---|
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Heart Rate; Humans; Imidazoles; Isoproterenol; Male; Phenoxyacetates; Phenoxypropanolamines; Propanolamines; Rats; Rats, Sprague-Dawley; Vascular Resistance; Xamoterol | 2011 |